Quadrant Capital Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-120
| Closed | -$4.91K | – | 2812 |
|
|
2024
Q2 | $4.91K | Hold |
120
| – | – | ﹤0.01% | 2295 |
|
|
2024
Q1 | $5.07K | Hold |
120
| – | – | ﹤0.01% | 2311 |
|
|
2023
Q4 | $5.09K | Buy |
120
+14
| +13% | +$594 | ﹤0.01% | 2274 |
|
|
2023
Q3 | $2.31K | Buy |
+106
| New | +$2.31K | ﹤0.01% | 2354 |
|
|
2023
Q1 | – | Sell |
-45
| Closed | -$1.42K | – | 2813 |
|
|
2022
Q4 | $1.42K | Buy |
+45
| New | +$1.42K | ﹤0.01% | 2481 |
|